Literature DB >> 16167908

Behçet's disease and pregnancy.

Jim Jadaon1, Asher Shushan, Yossef Ezra, Hen Y Sela, Cuneyt Ozcan, Nathan Rojansky.   

Abstract

BACKGROUND: Behçet's disease (BD) is a multisystem inflammatory chronic disorder, which is characterized by relapsing oral and genital ulceration and iridocyclitis. While being of unknown etiology, vasculitic changes of possible autoimmune origin are common to all involved organs, and thrombotic complications, which may adversely affect gestation, are frequently seen. Very little is known to date about the reciprocal influence of BD and pregnancy. We have undertaken to explore the mutual effect of BD and pregnancy with emphasis on maternal and fetal complications.
METHODS: In this case-control study, we have evaluated pregnancies that occurred in women suffering from BD, who were treated in our institution during the last 25 years. All records were reviewed, and data were confirmed by a telephone interview and compared with a matched control group. To review the current knowledge, a Medline search together with a manual search of selected articles was performed.
RESULTS: Thirty-one Behçet's patients who had 135 pregnancies were studied. Remissions were significantly more frequent during both pregnancy and postpartum periods, while exacerbations were observed only in one-sixth of the patients (P < 0.001). Pregnancy complications (P < 0.001), cesarean section (P < 0.001), and miscarriage (P < 0.02) rates, however, were significantly higher in the study group.
CONCLUSIONS: Our study suggests that pregnancy does not have a deleterious effect on the course of BD and may possibly ameliorate its course. However, it seems that BD may adversely affect pregnancy. The miscarriage rate was higher, and the pregnancy complications and cesarean section rates were significantly elevated.

Entities:  

Mesh:

Year:  2005        PMID: 16167908     DOI: 10.1111/j.0001-6349.2005.00761.x

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  11 in total

1.  Behcet's disease.

Authors:  Jagdish R Nair; Robert J Moots
Journal:  Clin Med (Lond)       Date:  2017-02       Impact factor: 2.659

Review 2.  [Management of patients with ocular diseases during pregnancy. Diabetes, glaucoma and uveitis].

Authors:  F Mackensen; R Max
Journal:  Ophthalmologe       Date:  2012-03       Impact factor: 1.059

Review 3.  Behçet's syndrome in pregnancy.

Authors:  Marcus Martineau; Dorian O Haskard; Catherine Nelson-Piercy
Journal:  Obstet Med       Date:  2010-03-04

4.  Adverse pregnancy outcomes in women with Behçet's disease: population-based registry linkage study in Taiwan.

Authors:  Tien-Ming Chan; Meng-Jiun Chiou; Chang-Fu Kuo
Journal:  Clin Rheumatol       Date:  2021-04-09       Impact factor: 2.980

Review 5.  [Rare autoimmune rheumatic illnesses during pregnancy. Systemic sclerosis, polymyositis/dermatomyositis and vasculitis].

Authors:  A Doria; L Iaccarino; A Ghirardello; S Arienti; S Zampieri; M E Rampudda; A Tincani; S Todesco
Journal:  Z Rheumatol       Date:  2006-05       Impact factor: 1.372

Review 6.  Managing pregnancy in inflammatory rheumatological diseases.

Authors:  Varsha Jain; Caroline Gordon
Journal:  Arthritis Res Ther       Date:  2011-02-25       Impact factor: 5.156

Review 7.  Autoimmune diseases and pregnancy: analysis of a series of cases.

Authors:  Vânia Gomes; Alexandra Mesquita; Carlos Capela
Journal:  BMC Res Notes       Date:  2015-06-04

8.  [Immunity impact of pregnancy on the experience of the Obstetrics and Gynecology Department of Moulay Ismail Military Hospital].

Authors:  Omar Laghzaoui
Journal:  Pan Afr Med J       Date:  2016-05-10

Review 9.  Knitting the Threads of Silk through Time: Behçet's Disease-Past, Present, and Future.

Authors:  Fahd Adeeb; Austin G Stack; Alexander D Fraser
Journal:  Int J Rheumatol       Date:  2017-09-10

Review 10.  Pregnancy Outcomes in Systemic Vasculitides.

Authors:  Carolyn Ross; Rohan D'Souza; Christian Pagnoux
Journal:  Curr Rheumatol Rep       Date:  2020-08-26       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.